Cen Biotech Inc (CENB) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CENB Annual Balance Sheets →
A period-by-period view of the balance sheet from Cen Biotech Inc to Sep 30 2021 helps clarify how Sep 30 2022's financial structure has changed over time.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2022)
(Jun 30 2022) (Mar 31 2022) (Dec 31 2021) (Sep 30 2021)
Assets
Cash & cash equivalent0.15
Cash & Short-term Investments0.00
Accounts receivable0.01
Income Taxes Receivable, Current NO0.03
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.11
Total Current Assets0.30
Equipment/Property/Plant Net0.07
Goodwill net1.28
Intangible Assets-4.82
Accounts Receivable, Net, Noncurrent1.30
Other Assets, Noncurrent9.00
Other Receivables Noncurrent0.01
Total Assets7.91
Liabilities
Accounts Payable, Current AC0.40
Accrued Liabilities, Current0.38
Loans Payable, Current NO1.69
Other Liabilities, Current7.36
Total Current Liabilities9.83
Long-term debt0.03
Total Long-term Debt0.03
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent0.16
Convertible Notes Payable Related Parties Current0.16
Interest Payable Related Party Current2.01
Acquisition Of Intangible Assets Liability Incurred Noncurrent0.00
Total Liabilities10.02
Stockholders' Equity
Additional Paid In Capital Common Stock44.92
Retained Earnings / Accumulated Deficit-46.99
Accumulated Other Comprehensive Income0.00
Other Equity-0.04
Common Stockholder's Equity-2.11
Total Stockholder's Equity-2.11
Liabilities & Stockholder's Equity7.91
4 historic quarters locked

Sign in to unlock the full Cen Biotech Inc balance sheet history.

About Cen Biotech Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-22-027170

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.